MedPath

Change in eGFR after adminstration of tolvaptan and furosemide in liver cirrhosis patients with ascites:a randomized study

Not Applicable
Conditions
liver cirrhosis
Registration Number
JPRN-UMIN000023881
Lead Sponsor
shonan kamakura general hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

1)The anuric patients 2)Patients with urinary retention 3)Serum Na >=147mEq/

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in eGFR levels from baseline after adminstraion of diuretic for 24 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath